Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Novavax Inc.

Start price
Target price
Perf. (%)
€183.96
17.12.21
€240.00
17.12.22
-37.46%
10.01.22

Could be worthwhile Investment >10% per year
Some uniques
Sievi 
17.12.21 50%
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€29.15
20.12.21
-
20.12.22
-12.35%
10.01.22

Top 10 in its market
Some uniques
Could be worthwhile Investment >10% per year
Sievi 
20.12.21 0%
buy
Genocea Biosciences Inc.

Start price
Target price
Perf. (%)
€1.15
27.12.21
-
27.12.22
-18.26%
10.01.22

Could be worthwhile Investment >10% per year
Sievi 
27.12.21 0%
buy
Hyundai Motor Co ADR

Start price
Target price
Perf. (%)
€48.00
09.01.21
€60.00
09.01.22
-24.17%
10.01.22

Normal challenges to pay loans and raise capital
Capable Management
Innovative
Stable Large shareholder and/or long term investor
skatcup 
09.01.21 80%
sell
Zeal Network SE

Start price
Target price
Perf. (%)
€40.10
09.01.21
€35.00
09.01.22
-2.12%
10.01.22

Top 10 in its market
Probably not worthwhile Investment
Low dividend yield expected
High valuation
Snowman 
09.01.21 70%
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€26.20
05.01.22
-
05.01.23
-4.58%
09.01.22

Risky Investment
Global_Player 
05.01.22 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€134.44
30.12.21
-
30.12.22
-13.81%
09.01.22

Risky Investment
Vassago1 
30.12.21 50%
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€33.72
03.01.22
-
03.01.23
-14.00%
09.01.22

Risky Investment
Vassago1 
03.01.22 50%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.54
03.01.22
-
03.01.23
-14.69%
09.01.22

Risky Investment
Wolf_of_WS 
03.01.22 50%
buy
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€0.88
20.12.21
€1.20
20.12.22
-25.64%
09.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
geldnutzer 
20.12.21 50%
buy
Overstock.com

Start price
Target price
Perf. (%)
€65.64
13.12.21
-
13.12.22
-27.86%
09.01.22

Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
FXX 
13.12.21 40%
buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€6.35
26.12.21
-
26.12.22
-7.81%
09.01.22

Risky Investment
bundfuture 
26.12.21 50%
buy
Sio Gene Therapies Inc.

Start price
Target price
Perf. (%)
€1.24
26.12.21
-
26.12.22
-7.74%
09.01.22

Risky Investment
bundfuture 
26.12.21 50%
buy
Qt Group Oyj

Start price
Target price
Perf. (%)
€59.80
08.01.21
€163.00
08.01.22
101.34%
09.01.22

Could be worthwhile Investment >10% per year
melinda 
08.01.21 50%
sell
Lightning Emotors Inc.

Start price
Target price
Perf. (%)
€179.70
11.08.21
€80.00
11.08.22
-33.78%
08.01.22

Capable Management
Probably not worthwhile Investment
Bad culture
Little innovation
dimontalban 
11.08.21 0%
buy
Carisma Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.58
21.08.21
€220.00
21.08.22
-13.54%
08.01.22

Revenue growth >5% per year expected
Undervalued
Probably not worthwhile Investment
Lower EBIT Margin than peer group
dimontalban 
21.08.21 30%
sell
Psi AG

Start price
Target price
Perf. (%)
€31.30
23.01.21
€26.00
23.01.22
35.46%
08.01.22

Some uniques
Probably not worthwhile Investment
Low dividend yield expected
Below average Management
Snowman 
23.01.21 50%
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€48.00
17.06.21
€60.00
17.06.22
-40.88%
08.01.22

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Snowman 
17.06.21 50%
buy
PVA TePla AG

Start price
Target price
Perf. (%)
€41.85
26.12.21
€48.00
26.12.22
-6.93%
08.01.22

EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Normal challenges to pay loans and raise capital
skatcup 
26.12.21 80%
buy
Secunet Security AG

Start price
Target price
Perf. (%)
€409.50
26.12.21
€450.00
26.12.22
-8.79%
08.01.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Valuable balance sheet
skatcup 
26.12.21 80%
buy
Valneva SE

Start price
Target price
Perf. (%)
€19.03
04.01.22
-
04.01.23
-7.46%
07.01.22

Risky Investment
thomasw 
04.01.22 50%
buy
Frequentis AG

Start price
Target price
Perf. (%)
€25.10
19.09.21
€30.00
19.09.22
36.26%
07.01.22

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Covacoro 
19.09.21 70%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€147.98
05.12.21
-
05.12.22
-23.17%
07.01.22

Could be worthwhile Investment >10% per year
melinda 
05.12.21 0%
sell
Yahoo Japan Corp

Start price
Target price
Perf. (%)
€5.85
02.11.21
-
02.11.22
-15.90%
07.01.22

Probably not worthwhile Investment
robertinio 
02.11.21 100%
sell
Infinity Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.92
28.07.21
-
28.07.22
-25.00%
06.01.22

Probably not worthwhile Investment
High valuation
tinelchen 
28.07.21 0%